Mannkind reported $22.21M in Sales Revenues for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Acceleron Pharma XLRN:US $ 34.2M 6.26M
Adamas Pharmaceuticals ADMS:US 25.9M 3.92M
Adma Biologics ADMA:US $ 20.68M 2.85M
Biocryst Pharmaceuticals BCRX:US $ 40.99M 8.96M
Biodelivery Sciences International BDSI:US $ 41.09M 0.35M
Chemocentryx CCXI:US $ 17.74M 15.93M
Dicerna Pharmaceuticals DRNA:US $ 62.95M 21.62M
Dynavax Technologies DVAX:US $ 108.27M 55.5M
Eli Lilly And LLY:US $ 6772.8M 32.7M
Flexion Therapeutics FLXN:US $ 21.33M 6.85M
Halozyme Therapeutics HALO:US $ 115.83M 20.62M
Immunogen IMGN:US $ 9.21M 7.74M
Insmed INSM:US $ 46.76M 1.39M
JAZZ PHA JAZZ:US $ 838.12M 86.3M
Karyopharm Therapeutics KPTI:US $ 37.69M 15.09M
Kindred Biosciences KIN:US $ 3.54M 1.14M
Macrogenics MGNX:US $ 15.66M 15.1M
Mannkind MNKD:US $ 22.21M 1.07M
Merk MRK:US $ 13154M 1752M
Minerva Neurosciences NERV:US $ 0 0
Novavax NVAX:US $ 178.84M 119.17M
Novo Nordisk A Fs NVO:US $ 35622M 2581M
Peregrine Pharmaceuticals PPHM:US $ 26.11M 4.64M
Pfizer PFE:US $ 24094M 5117M
Xencor XNCR:US $ 19.68M 47.76M